Preparation of rifampicin-loaded PLGA microspheres for lung delivery as aerosol by premix membrane homogenization

International Journal of Pharmaceutics

Volumn 382, Issue 1-2, 2009, Pages 61-66

  Doan, T V P ^a,b   Olivier, J C ^a,b  

^a INSERM   (France)

^b UNIVERSITÉ DE POITIERS   (France)

Author keywords

Microspheres; PLGA; Premix membrane emulsification; Rifampicin; SPG membrane

Indexed keywords

ACETIC ACID ETHYL ESTER; MICROSPHERE; OIL; PHOSPHATE; POLYGLACTIN; RIFAMPICIN; SODIUM CHLORIDE; WATER;

AEROSOL; ARTICLE; DRUG DELIVERY SYSTEM; EMULSION; FREEZE DRYING; POROSITY; PRIORITY JOURNAL; SUSTAINED RELEASE FORMULATION; TISSUE HOMOGENATE;

ACETATES; ADMINISTRATION, INHALATION; AEROSOLS; ANIMALS; ANTI-BACTERIAL AGENTS; CHEMISTRY, PHARMACEUTICAL; DELAYED-ACTION PREPARATIONS; DRUG CARRIERS; DRUG COMPOUNDING; EMULSIONS; KINETICS; LACTIC ACID; MEMBRANES, ARTIFICIAL; MICROSPHERES; OILS; PARTICLE SIZE; POLYGLYCOLIC ACID; PRESSURE; RATS; RIFAMPIN; SOLUBILITY; SOLVENTS; TECHNOLOGY, PHARMACEUTICAL; WATER;

EID: 70350324932     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2009.08.008     Document Type: Article

References (20)

1. Bosquillon C., Préat V., and Vanbever R. Pulmonary delivery of growth hormone using dry powders and visualization of its local fate in rats. J. Control. Release 96 (2004) 233-244
2. Dudley M.N., Loutit J., and Griffith D.C. Aerosol antibiotics: considerations in pharmacological and clinical evaluation. Curr. Opin. Biotechnol. 19 (2008) 637-643
3. Ito F., Fujimori H., Honnami H., Kawakami H., Kanamura K., and Makino K. Study of types and mixture ratio of organic solvent used to dissolve polymers for preparation of drug-containing PLGA microspheres. Eur. Polym. J. 45 (2009) 658-667
4. Jafari S.M., Assadpoor E., He Y., and Bhandari B. Re-coalescence of emulsion droplets during high-energy emulsification. Food Hydrocolloids 22 (2008) 1191-1202
5. Le Brun P.P.H., de Boer A.H., Mannes G.P.M., de Fraîture D.M.I., Brimicombe R.W., Touw D.J., Vinks A.A., Frijlink H.W., and Heijerman H.G.M. Dry powder inhalation of antibiotics in cystic fibrosis therapy. Part 2. Inhalation of a novel colistin dry powder formulation: a feasibility study in healthy volunteers and patients. Eur. J. Pharm. Biopharm. 54 (2002) 25-32
6. Ma G., Nagai M., and Omi S. Preparation of uniform poly(lactide) microspheres by employing the Shirasu porous glass (SPG) emulsification technique. Colloid Surf. A 153 (1999) 383-394
7. Makino K., Nakajima T., Shikamura M., Ito F., Ando S., Kochi C., Inagawa H., Soma G.I., and Terada H. Efficient intracellular delivery of rifampicin to alveolar macrophages using rifampicin-loaded PLGA microspheres: effects of molecular weight and composition of PLGA on release of rifampicin. Colloid Surf. B 36 (2004) 35-42
8. O'Hara P., and Hickey A.J. Respirable PLGA microspheres containing rifampicin for the treatment of tuberculosis: manufacture and characterization. Pharm. Res. 17 (2000) 955-961
9. Sakagami M., and Byron P.R. Respirable microspheres for inhalation: the potential of manipulating pulmonary disposition for improved therapeutic efficacy. Clin. Pharmacokinet. 44 (2005) 263-277
10. Sah H. Microencapsulation techniques using ethyl acetate as a dispersed solvent: effects of its extraction rate on the characteristics of PLGA microspheres. J. Control. Release 47 (1997) 233-245
11. Sawalha H., Purwanti N., Rinzema A., Schroën K., and Boom R. Polylactide microspheres prepared by premix membrane, emulsification-Effects of solvent removal rate. J. Membr. Sci. 310 (2008) 484-493
12. Suarez S., O'Hara P., Kazantseva M., Newcomer C.E., Hopfer R., McMurray D.N., and Hickey A.J. Respirable PLGA microspheres containing rifampicin for the treatment of tuberculosis: screening in an infectious disease model. Pharm. Res. 18 (2001) 1315-1319
13. Telko M.J., and Hickey A.J. Dry powder inhaler formulation. Respir. Care 50 (2005) 1209-1227
14. Tewes F., Brillault J., Couet W., and Olivier J.-C. Formulation of rifampicin-cyclodextrin complexes for lung nebulisation. J. Control. Release 129 (2008) 93-99
15. Vladisavljević G.T., and Schubert H. Influence of process parameters on droplet size distribution in SPG membrane emulsification and stability of prepared emulsion droplets. J. Membr. Sci. 225 (2003) 15-23
16. Vladisavljević G.T., Shimizu M., and Nakashima T. Production of multiple emulsions for drug delivery systems by repeated SPG membrane homogenization: influence of mean pore size, interfacial tension and continuous phase viscosity. J. Membr. Sci. 284 (2006) 373-383
17. Vladisavljević G.T., Shimizu M., and Nakashima T. Preparation of monodisperse multiple emulsions at high production rates by multi-stage premix membrane emulsification. J. Membr. Sci. 244 (2004) 97-106
18. Vladisavljević G.T., and Williams R.A. Recent developments in manufacturing emulsions and particulate products using membranes. Adv. Colloid Interface Sci. 113 (2005) 1-20
19. Wei Q., Wei W., Tian R., Wang L.-y., Su Z.-G., and Ma G.-H. Preparation of uniform-sized PELA microspheres with high encapsulation efficiency of antigen by premix membrane emulsification. J. Colloid Interface Sci. 323 (2008) 267-273
20. Westerman E.M., Le Brun P.P.H., Touw D.J., Frijlink H.W., and Heijerman H.G.M. Effect of nebulized colistin sulphate and colistin sulphomethate on lung function in patients with cystic fibrosis: a pilot study. J. Cyst. Fibros. 3 (2004) 23-28